Evidence map›Paper›PMID 38341201›Full record

ArticleBMJ open2024

Trends of mean systolic and diastolic blood pressure among adults in Shenzhen, China, 1997-2018: findings from three rounds of the population-based survey.

Ke Peng, Weicong Cai, Xiaoying Liu, Yishu Liu, Menglu Ouyang, Jessica Gong, Zhihui Wang, Yunfeng Wang, Jing Hao, Wei Wang and 8 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 3 countries.

Ke Peng *Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Guangdong, China.ORCID 0009-0008-1939-1650
Weicong Cai *Shenzhen Center for Chronic Disease Control, Shenzhen, Guangdong, China.
Xiaoying Liu *Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Guangdong, China.
Yishu LiuThe George Institute for Global Health, Beijing, China.ORCID 0000-0002-4157-7506
Menglu OuyangThe George Institute for Global Health, Newtown, New South Wales, Australia.
Jessica GongImperial College London, London, UK.
Zhihui WangChinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Yunfeng WangFuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Guangdong, China.
Jing HaoShenzhen Mindray Bio-Medical Electronic Co, Shenzhen, China.
Wei WangNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.ORCID 0000-0003-4232-8699
Honglei ZhaoFuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Guangdong, China.
Kaihao LinShenzhen Center for Chronic Disease Control, Shenzhen, Guangdong, China.
Guiyuan HanFuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Guangdong, China.
Yu ShiFuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Guangdong, China.
Yinghao XieFuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Guangdong, China.
Yuxin XieFuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Guangdong, China.
Lin LeiShenzhen Center for Chronic Disease Control, Shenzhen, Guangdong, China lin.leilana@gmail.com.
Lei SiWestern Sydney University, Penrith South, New South Wales, Australia.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNShenzhen Nanshan Center for Chronic Disease Control · CNGeorge Institute for Global Health · CNImperial College London · GBMindray (China) · CNNational Center for Chronic and Noncommunicable Disease Control and Prevention · CNPeking University · CNUNSW Sydney · AUWestern Sydney University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo quantify the trends in systolic and diastolic blood pressure (BP) among adults in Shenzhen from 1997 to 2018.

designCross-sectional study. SETTINGS: The data were collected from all districts in Shenzhen, China in the years of 1997, 2009 and 2018 by multistage cluster sampling procedure.

participantsParticipants were residents aged 18-69 years in Shenzhen, China. A total of 26 621 people were included: 8266 people in 1997, 8599 people in 2009 and 9756 people in 2018. PRIMARY AND SECONDARY OUTCOME MEASURES: All participants were surveyed about their sociodemographic and lifestyle information. BP was measured by trained physicians using a mercury sphygmomanometer. Hypertension was defined as systolic BP of at least 140 mm Hg and diastolic BP of at least 90 mm Hg, self-reported use of antihypertensive medications or both. Hypertension control was defined as systolic BP values of less than 140 mm Hg and diastolic BP values of less than 90 mm Hg.

resultAge-adjusted mean systolic BP increased from 117±16 mm Hg to 123±15 mm Hg (p<0.001) in males, and from 113±18 mm Hg to 115±16 mm Hg (p<0.001) in females from 1997 to 2018. Diastolic BP among males increased from 75 mm Hg (SD=11) to 79 mm Hg (SD=11) and increased from 71 mm Hg (SD=10) to 73 mm Hg (SD=10) among females between 1997 and 2018 (p<0.001). Rate of hypertension rose rapidly from 17.71% (95% CI: 16.60% to 18.90%) in 2009 to 24.01% (95% CI: 22.84% to 25.22%) in 2018 among males (p<0.001), whereas the prevalence among females remained stable at around 13.5% (p=0.98). Both awareness and treatment rates of hypertension among males and females showed a decreased trend between 2009 and 2018, while no significant changes were observed for control rates.

conclusionsThe mean systolic BP and diastolic BP among adults in Shenzhen increased from 1997 to 2018, and no improvements in hypertension awareness, treatment and control rates were found.

Indexed as

HypertensionAdultAntihypertensive AgentsBlood PressureChinaCross-Sectional StudiesFemaleHumansMaleAntihypertensive AgentsBlood PressureEPIDEMIOLOGYHypertension

Identifiers

PMID38341201
PMCPMC10862306
OpenAlexW4392731064

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.